Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
essential tremor
Biotech
Praxis plots path to FDA after phase 3 wins in essential tremor
The trials demonstrated the benefits of ulixacaltamide in essential tremor after a previously grim outlook from one study earlier this year.
Zoey Becker
Oct 16, 2025 11:48am
Encora names CEO as co-founder, and previous chief takes VP role
Oct 7, 2025 9:30am
FDA clears Fasikl AI stimulation wristwatch for essential tremor
Jul 3, 2025 9:15am
Praxis moves ahead despite phase 3 tremor trial futility finding
Feb 28, 2025 9:11am
Cala raises $50M to boost its wearable hand tremor therapy
Dec 9, 2024 10:58am
Acadia inks $582M biobucks pact for Danish biotech's neuro asset
Nov 26, 2024 5:00pm